FIELD: medicinal radio-biology. SUBSTANCE: in lymphocytes of individual's peripheral blood, double-centerd-type chromosomal aberrations and percentage of E- 47-type rosette-forming lymphocytes are determined and, when value of the latter is less than its average value (found in healthy controls), individual is regarded as being the subject of radiation effect in dose up to 0.2 Gr, which cannot be reliably revealed by any of now existing techniques. Determination of E-47-type rosette-forming lymphocytes should be performed not earlier than 6 months after possible irradiation. EFFECT: increased accuracy of biological indication. 2 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTING REMOTE AFTEREFFECTS OF RADIATION IMPACT IN LOW DOSAGES | 2002 |
|
RU2210351C1 |
METHOD FOR CORRECTING REMOTE AFTEREFFECTS OF RADIATION IMPACT AT LOW DOSAGES | 2005 |
|
RU2268031C1 |
METHOD FOR TREATMENT OF MALIGNANT TUMORS OF OVARY | 1995 |
|
RU2078598C1 |
METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF WATER IN CASES OF LOW DOSE RADIATION EXPOSURE | 1999 |
|
RU2146370C1 |
METHOD OF TREATMENT OF CARCINOMA OF LUNGS | 1997 |
|
RU2128066C1 |
METHOD FOR TREATING THE CASES OF OVARIAN CARCINOMA RELAPSE | 2005 |
|
RU2273502C1 |
METHOD TO TREAT PATIENTS IRRADIATED WITH LOW-IONIZING RADIATION AT ASTHENONEUROTIC SYNDROME ALONG WITH VEGETOVASCULAR DYSTONIA | 1993 |
|
RU2082381C1 |
METHOD TO PREDICT RELAPSE OF SOLID TUMORS | 2001 |
|
RU2184971C1 |
METHOD OF RETARDATION OF MALIGNANT TUMOR GROWTH | 1998 |
|
RU2143935C1 |
METHOD FOR PREDICTING HORMONE DEPENDENCE OF MAMMARY GLAND CARCINOMA | 2002 |
|
RU2194992C1 |
Authors
Dates
1999-02-10—Published
1997-10-09—Filed